Biote Q2 2024 GAAP EPS $(0.19) Misses $0.09 Estimate, Sales $49.169M Beat $49.062M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biote (NASDAQ:BTMD) reported Q2 2024 GAAP EPS of $(0.19), missing the $0.09 estimate by 311.11%. Sales were $49.169M, slightly beating the $49.062M estimate. EPS improved by 24% YoY, while sales decreased by 0.18% YoY.
August 08, 2024 | 9:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Biote's Q2 2024 earnings report showed a significant EPS miss but a slight sales beat. The EPS of $(0.19) missed the $0.09 estimate by a large margin, while sales of $49.169M slightly exceeded expectations. EPS improved by 24% YoY, but sales saw a slight decline of 0.18% YoY.
The significant EPS miss is likely to negatively impact the stock price in the short term, despite the slight sales beat. The market often reacts strongly to large deviations from EPS estimates.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100